Risk Factors
437 articles
Cachexia Research Gaining Momentum
Why do pancreatic cancer patients lose weight even if they are eating well? Dr. Teresa Zimmers explains the syndrome called cachexia.
A Look at MEK and Autophagy Inhibition
Dr. Conan Kinsey looks at the MEK pathway as way to make immunotherapy more effective for pancreatic cancer patients.
Gut Reaction for Pancreatic Cancer
Dr. Florencia McAllister and her team are looking at the tumor microbiome to develop effective pancreatic cancer treatments.
Two New Immunotherapy Trials Aim to Make Therapy More Effective
Two clinical trials in the Lustgarten Foundation’s Clinical Accelerator are testing different combinations of immunotherapy.
Breathe Happy
When Helene Avraham-Katz was diagnosed with pancreatic cancer, she and her family made the decision to fight it with everything they could.
I’m Going to Live Every Day
Sharon Simone got a second opinion that led to a treatment protocol suited to her BRCA1 mutation. Now she is a long-term survivor.
Hope For All Stages
The doctors and researchers at the Penn Pancreatic Cancer Research Center examine different aspects of pancreatic cancer to find better treatments.
Research Updates from ASCO GI 2023
Read the latest clinical trial and research updates from the 2023 ASCO GI meeting, including a review of genetic testing uptake.
Integrative Oncology Explained
Dr. Santosh Rao believes in the value of integrative oncology, which treats the whole person, not just the patient.
Hope is Everything You Have
Long-term survivor Eric Borden believes in the importance of advocating for yourself with your doctors; if he hadn’t he might not be here.
Find the Joy in Your Life Every Day
Long-term survivor Donna Robinson decided to focus on joy rather than fear during treatment for pancreatic cancer.
New Study Targets Specific BRAF Mutation
One type of BRAF mutation may provide a target for treatment in pancreatic cancer patients, explains Dr. Michael Pishvaian.
Targeting Pancreatic Cancer Cell Growth
Researchers are testing a new drug targeting cell growth in solid tumors, including pancreatic cancer.
Listen to the Patient
Long-term survivor Michael Whalen is here because he pushed his doctors to follow up on his concern about possibly having pancreatic cancer.
Phase II mRNA Vaccine Trial Opens
The mRNA vaccine phase II clinical trial, led by Dr. Vinod Balachandran, has opened at Memorial Sloan Kettering, with other locations soon to come.